CCL4 and type 1 diabetes mellitus: Tregs deficient in CCL3 and CCL4 fail to prevent the progression of experimental autoimmune encephalomyelitis or islet allograft rejection in murine models and Tregs from individuals with type 1 diabetes demonstrate an impaired ability to produce CCL3 and CCL4 (268).